mibefradil has been researched along with Bradyarrhythmia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ritz, E; Wagner, J | 1 |
| Krum, H; McNeil, JJ | 1 |
| Prpic, R; Rogers, R | 1 |
3 other study(ies) available for mibefradil and Bradyarrhythmia
| Article | Year |
|---|---|
[Induction of bradycardia by mibefradil in antihypertensive combination therapy].
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Bradycardia; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Male; Mibefradil; Tetrahydronaphthalenes | 1998 |
The short life and rapid death of a novel antihypertensive and antianginal agent.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Benzimidazoles; Bradycardia; Calcium Channel Blockers; Conflict of Interest; Drug Interactions; Drug Therapy, Combination; Humans; Mibefradil; Tachycardia; Tetrahydronaphthalenes | 1998 |
Profound symptomatic bradycardia associated with combined mibefradil and beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Aged; Benzimidazoles; Bradycardia; Calcium Channel Blockers; Cardiac Pacing, Artificial; Drug Therapy, Combination; Electrocardiography; Female; Humans; Mibefradil; Middle Aged; Tetrahydronaphthalenes; Vasodilator Agents | 1998 |